Business Context and Reporting Period
Company: Penumbra, Inc.
Filing Type: Form 8-K (Current Report)
Date: December 15, 2020
Event: Voluntary recall of the Penumbra JET 7 Reperfusion Catheter with Xtra Flex technology ("JET 7 Xtra Flex").
Key Financial Metrics and Impact
The filing details a specific financial impact related to the product recall rather than providing full period financial statements.
- Revenue Impact: Expected one-time reduction to revenue of less than $20 million in the fourth quarter ending December 31, 2020, to account for product returns.
- Cost Impact: Anticipated increase in cost of sales due to inventory write-offs and, to a lesser extent, increased selling, general, and administrative expenses.
- Product Contribution: The recalled product represented 7.5% of total third-quarter revenue.
- Liquidity and Debt: The filing text does not provide clear values for total debt, liquidity, or cash flow positions.
Material Changes and Unusual Items
The primary material change is the voluntary recall of all configurations of the JET 7 Xtra Flex catheter due to susceptibility to distal tip damage during use. This event triggers a significant, non-recurring financial adjustment in the fourth quarter of 2020.
Guidance, Outlook, and Risks
- Outlook: The Company may incur additional costs in future quarters beyond the initial Q4 estimate.
- Uncertainty: The total cost of the recall is not yet fully ascertained. The Company states that the actual loss may differ materially from the current best estimate.
- Management Commentary: Full details regarding the financial statement impact will be addressed during the fourth-quarter earnings call.
- Risk: Potential for further financial impact if additional costs arise in subsequent periods.
Investor Verification Checklist
- Verify the final financial impact of the recall during the Q4 2020 earnings call.
- Monitor for any additional costs incurred in future quarters beyond the initial estimate.
- Assess the impact of the 7.5% revenue loss from JET 7 Xtra Flex on overall growth trajectory.
- Review the press release (Exhibit 99.1) for specific details on the recall scope and customer communication.